Hideaki Kishimoto - Concepedia

Author

Hideaki Kishimoto

Tottori University

Also Known As

HIDEAKI KISHIMOTO, Hideaki KISHIMOTO, Hideaki Kishimoto, Kishimoto Hideaki

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Tottori University Kawasaki Medical School Sanin Rosai Hospital Hamamatsu University School of Medicine University of Occupational and Environmental Health Japan

About

Hideaki Kishimoto is an author at Tottori University specializing in osteoporosis, medicine, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	959
2	Orthopaedics	10	10	389
3	Health Sciences	2	2	59
4	Obstetrics	2	2	95
5	Pharmacology	1	1	88

Hideaki Kishimoto

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Diagnostic criteria for primary osteoporosis: year 2000 revision Hajime Orimo, Yasufumi Hayashi, Masao Fukunaga, Journal of Bone and Mineral Metabolism Bone DiseasePrimary OsteoporosisDiagnosisBone DensityMedicine	2001	463
Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk Toshitaka Nakamura, Toshitsugu Sugimoto, Tetsuo Nakano, The Journal of Clinical Endocrinology & Metabolism	2012	254
Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules Tetsuo Inoue, Toshiharu Fujita, Hideaki Kishimoto, Journal of Bone and Mineral Metabolism Bone DiseaseBone HealthMedicineFracture HealingOf Study	2008	88
Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA Hideaki Kishimoto, Masayuki Maehara Archives of Osteoporosis	2015	81
Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study K. Kushida, Masataka Shiraki, Toshitaka Nakamura, Journal of Bone and Mineral Metabolism Bone DiseaseBone HealthVertebral Fracture Risk3-Year Follow-up StudyPostmenopausal Japanese Women	2004	60
A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial K. Kushida, Masao Fukunaga, Hideaki Kishimoto, Journal of Bone and Mineral Metabolism Skeletal TraumaJapanese PatientsBone HealthInvolutional OsteoporosisSurgery	2004	57
A Placebo-Controlled, Single-Blind Study to Determine the Appropriate Alendronate Dosage in Postmenopausal Japanese Patients with Osteoporosis. Masataka Shiraki, K. Kushida, Masao Fukunaga, Endocrine Journal	1998	52
Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen Hideaki Kishimoto, Masao Fukunaga, Kazuhiro Kushida, Journal of Bone and Mineral Metabolism Bone DiseaseBone HealthInvolutional OsteoporosisPharmacotherapyBone Density	2006	49
The efficacy of alendronate in reducing the risk for vertebral fracture in japanese patients with osteoporosis: A randomized, double-blind, active-controlled, double-dummy trial Kazuhiro Kushida, Masataka Shiraki, Nakamura Toshitaka, Current Therapeutic Research Bone DiseaseVertebral FractureBone HealthDouble-dummy TrialMedicine	2002	47
Bone disorder following partial and total gastrectomy with reference to bone mineral content Okitsugu Nishimura, Toyokazu Furumoto, Kimiyasu Nosaka, Surgery Today Bone DiseaseBone ImagingBone DisorderTotal GastrectomyMedicine	1986	39

Page 1